Altering calcium sensitivity in heart failure: a crossroads of disease etiology and therapeutic innovation

NS Saad, MA Mashali, SJ Repas… - International journal of …, 2023 - mdpi.com
Heart failure (HF) presents a significant clinical challenge, with current treatments mainly
easing symptoms without stopping disease progression. The targeting of calcium (Ca2+) …

A novel endocrine role for the BAT-released lipokine 12, 13-diHOME to mediate cardiac function

KM Pinckard, VK Shettigar, KR Wright, E Abay… - Circulation, 2021 - Am Heart Assoc
Background: Brown adipose tissue (BAT) is an important tissue for thermogenesis, making it
a potential target to decrease the risks of obesity, type 2 diabetes, and cardiovascular …

[HTML][HTML] A tension-based model distinguishes hypertrophic versus dilated cardiomyopathy

J Davis, LC Davis, RN Correll, CA Makarewich… - Cell, 2016 - cell.com
The heart either hypertrophies or dilates in response to familial mutations in genes encoding
sarcomeric proteins, which are responsible for contraction and pumping. These mutations …

Mouse Models of Cardiomyopathies Caused by Mutations in Troponin C

SB Tikunova, J Thuma, JP Davis - International journal of molecular …, 2023 - mdpi.com
Cardiac muscle contraction is regulated via Ca2+ exchange with the hetero-trimeric troponin
complex located on the thin filament. Binding of Ca2+ to cardiac troponin C, a Ca2+ sensing …

Bioengineering of injectable encapsulated aggregates of pluripotent stem cells for therapy of myocardial infarction

S Zhao, Z Xu, H Wang, BE Reese… - Nature …, 2016 - nature.com
It is difficult to achieve minimally invasive injectable cell delivery while maintaining high cell
retention and animal survival for in vivo stem cell therapy of myocardial infarction. Here we …

Umbrella sampling simulations measure switch peptide binding and hydrophobic patch opening free energies in cardiac troponin

AM Cool, S Lindert - Journal of chemical information and …, 2022 - ACS Publications
The cardiac troponin (cTn) complex is an important regulatory protein in heart contraction.
Upon binding of Ca2+, cTn undergoes a conformational shift that allows the troponin I switch …

Myofilament calcium sensitivity: consequences of the effective concentration of troponin I

JK Siddiqui, SB Tikunova, SD Walton, B Liu… - Frontiers in …, 2016 - frontiersin.org
Control of calcium binding to and dissociation from cardiac troponin C (TnC) is essential to
healthy cardiac muscle contraction/relaxation. There are numerous aberrant post …

Gene Transfer of engineered calmodulin alleviates ventricular arrhythmias in a calsequestrin‐associated mouse model of catecholaminergic polymorphic ventricular …

B Liu, SD Walton, HT Ho, AE Belevych… - Journal of the …, 2018 - Am Heart Assoc
Background Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a familial
arrhythmogenic syndrome characterized by sudden death. There are several genetic forms …

Changes in the dynamics of the cardiac troponin C molecule explain the effects of Ca2+-sensitizing mutations

CM Stevens, K Rayani, G Singh, B Lotfalisalmasi… - Journal of Biological …, 2017 - ASBMB
Cardiac troponin C (cTnC) is the regulatory protein that initiates cardiac contraction in
response to Ca 2+. TnC binding Ca 2+ initiates a cascade of protein–protein interactions …

The lack of Troponin I Ser-23/24 phosphorylation is detrimental to in vivo cardiac function and exacerbates cardiac disease

HE Salhi, V Shettigar, L Salyer, S Sturgill… - Journal of molecular and …, 2023 - Elsevier
Troponin I (TnI) is a key regulator of cardiac contraction and relaxation with TnI Ser-23/24
phosphorylation serving as a myofilament mechanism to modulate cardiac function. Basal …